Infinity Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Current
Infinity Pharmaceuticals, Inc. had Debt Securities, Available-for-sale, Current of $10.74 million as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2022-08-09
- 2022-06-30: Debt Securities, Available-for-sale, Current $10.74M.
- 2022-03-31: Debt Securities, Available-for-sale, Current $14.02M.
- 2021-12-31: Debt Securities, Available-for-sale, Current $0.00.
- 2021-09-30: Debt Securities, Available-for-sale, Current $0.00.
| Period end | Debt Securities, Available-for-sale, Current | Debt Securities, Available-for-sale, Current as first filed |
|---|---|---|
| 2022-06-30 | $10.74M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $14.02M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-08-09 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $5.51M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $22.76M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $13.81M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $19.86M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $20.18M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $30.40M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $20.37M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $17.58M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $9.97M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $9.95M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $17.24M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $23.00M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $22.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $18.00M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $13.79M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $24.04M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $79.21M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $57.06M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $25.68M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $64.87M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $10.01M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $25.32M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $57.74M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $55.64M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $116.56M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $145.77M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $196.82M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $221.43M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $201.43M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $150.28M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $135.85M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $84.26M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $80.83M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $91.08M 10-K · filed 2013-03-05 | $91.08M 10-K · filed 2012-03-13 |
| 2011-09-30 | $51.52M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $64.18M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $79.80M 10-K · filed 2012-03-13 |